is retatrutide approved in other countries ⚠️ BEWARE OF SOLD ONLINE! There are many "miracle" weight loss solutions spreading on social media, but not all are safe. Retatrutide still undergoing clinical trials and NO FDA APPROVAL Retatrutide (LY3437943) | GCGR/GIPR/GLP-1R Agonist
Description
Constipation is a common side effect of weight management and diabetes medications like semaglutide (Wegovy) and tirzepatide (Mounjaro)
Downstream effects may include negative implications for packaging companies and food retailers as volume trends for specific products plateau or decline
Recommendations from the international evidencebased guideline for the assessment and management of polycystic ovary syndrome
Focus on consistency over perfection
Conclusions GLP-1 agonists reduce fetal survival, weight, growth and skeletal ossification and can induce major congenital anomalies
JAMA Cardiol
